非酒精性脂肪性肝病:颈动脉粥样硬化患者复发性缺血性卒中及短暂性脑缺血发作的新预测因素
这项回顾性研究纳入742例颈动脉粥样硬化患者,经腹部平扫CT诊断非酒精性脂肪性肝病,随访2.9年(四分位距2.1-3.9)期间166例达到临床终点。多变量Cox分析显示非酒精性脂肪性肝病与复发性卒中或短暂性脑缺血发作相关,包含非酒精性脂肪性肝病、临床数据和斑块特征的联合模型预测效能最佳(AUC=0.79)。
要点
- 颈动脉粥样硬化患者中,腹部平扫CT诊断的非酒精性脂肪性肝病与复发性缺血性卒中或短暂性脑缺血发作相关。
- 联合非酒精性脂肪性肝病、临床数据及斑块特征的模型预测复发性卒中或短暂性脑缺血发作的AUC为0.79。
- 非酒精性脂肪性肝病可能作为新的影像标志物用于临床心血管疾病预防。
核心结论
- 非酒精性脂肪性肝病有助于预测复发性缺血性卒中或短暂性脑缺血发作,可能成为临床预防心血管疾病的新影像标志物。
研究设计与样本
- 回顾性研究,纳入2013年1月至2021年12月期间接受颈动脉CT血管造影的742例颈动脉粥样硬化患者(平均年龄64.26±9.42岁,497例男性),非酒精性脂肪性肝病由腹部平扫CT诊断,临床终点为复发性缺血性卒中或短暂性脑缺血发作。
诊断标准与关键数值
- 非酒精性脂肪性肝病由腹部平扫CT诊断。
- 联合模型(包含非酒精性脂肪性肝病、临床数据和斑块特征)预测临床终点的AUC=0.79。
临床应用与阅片要点
- 作者认为非酒精性脂肪性肝病可能作为新的影像标志物,为临床预防心血管疾病提供新视角。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. This study focused on assessing the predictive significance of NAFLD for recurrent stroke and transient ischemic attack (TIA) risk to determine the value of NAFLD.
METHOD: This study included 742 participants (mean age: 64.26 ± 9.42 years, 497 males) with carotid atherosclerosis who underwent carotid CT angiography (CTA) between January 2013 and December 2021 in this retrospective study. NAFLD was diagnosed by non-enhanced abdominal CT. The clinical endpoint was a recurrent ischemic stroke or TIA. Cox proportional hazards and Kaplan-Meier analysis assessed whether NAFLD was associated with the endpoint. We accessed the predictive values of NAFLD, clinical, plaque characteristics, and combined model by the C statistics. The predictive performance of the combined model was assessed by receiver operating characteristic curve (ROC) analysis.
RESULTS: A total of 742 participants (mean age: 64.26 ± 9.42 years, 497 males) were included. During 2.9 years of follow-up (interquartile range, 2.1-3.9), 166 patients reached the clinical endpoint. Multivariable cox analyses showed NAFLD was associated with recurrent stroke or TIA in all groups (all P<0.05). Patients with NAFLD had a lower event-free survival (EFS) rate than those without NAFLD (P<0.05). The combined model, including NAFLD, clinical data and plaque features, showed the best performance in predicting the clinical endpoint (AUC=0.79).
CONCLUSIONS: NAFLD contributes to the prediction of recurrent ischemic stroke or TIA. NAFLD may be a novel imaging marker that offers a new perspective on preventing cardiovascular disease in the clinic.
引用
- Xu T, Li S, Wu S, et al. Non-alcoholic fatty liver disease: A new predictor of recurrent ischemic stroke and transient ischemic attack in patients with carotid atherosclerosis. Eur J Radiol. 2024. PMID: 39341166. doi:10.1016/j.ejrad.2024.111754
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。